1. Home
  2. RPHM vs KORE Comparison

RPHM vs KORE Comparison

Compare RPHM & KORE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPHM
  • KORE
  • Stock Information
  • Founded
  • RPHM 2014
  • KORE 2003
  • Country
  • RPHM United States
  • KORE United States
  • Employees
  • RPHM N/A
  • KORE N/A
  • Industry
  • RPHM Biotechnology: Pharmaceutical Preparations
  • KORE Telecommunications Equipment
  • Sector
  • RPHM Health Care
  • KORE Consumer Discretionary
  • Exchange
  • RPHM Nasdaq
  • KORE Nasdaq
  • Market Cap
  • RPHM 47.5M
  • KORE 50.8M
  • IPO Year
  • RPHM 2021
  • KORE N/A
  • Fundamental
  • Price
  • RPHM $1.70
  • KORE $2.30
  • Analyst Decision
  • RPHM Hold
  • KORE Buy
  • Analyst Count
  • RPHM 6
  • KORE 3
  • Target Price
  • RPHM $2.26
  • KORE $7.67
  • AVG Volume (30 Days)
  • RPHM 316.0K
  • KORE 7.8K
  • Earning Date
  • RPHM 11-11-2024
  • KORE 11-07-2024
  • Dividend Yield
  • RPHM N/A
  • KORE N/A
  • EPS Growth
  • RPHM N/A
  • KORE N/A
  • EPS
  • RPHM N/A
  • KORE N/A
  • Revenue
  • RPHM N/A
  • KORE $284,942,000.00
  • Revenue This Year
  • RPHM N/A
  • KORE $3.55
  • Revenue Next Year
  • RPHM N/A
  • KORE $5.72
  • P/E Ratio
  • RPHM N/A
  • KORE N/A
  • Revenue Growth
  • RPHM N/A
  • KORE 7.91
  • 52 Week Low
  • RPHM $0.98
  • KORE $1.30
  • 52 Week High
  • RPHM $9.21
  • KORE $6.45
  • Technical
  • Relative Strength Index (RSI)
  • RPHM 61.53
  • KORE 50.11
  • Support Level
  • RPHM $1.61
  • KORE $2.11
  • Resistance Level
  • RPHM $1.75
  • KORE $2.40
  • Average True Range (ATR)
  • RPHM 0.12
  • KORE 0.18
  • MACD
  • RPHM 0.03
  • KORE 0.03
  • Stochastic Oscillator
  • RPHM 81.25
  • KORE 59.57

About RPHM Reneo Pharmaceuticals Inc.

Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates a majority of its revenue from the United States and the rest from other countries.

Share on Social Networks: